P

Pablo Altman

Novartis (United States)

ORCID: 0000-0002-4799-903X

44 papers and 1.4k citations.

PubIndex Score36Top 64% · mid-careerHow it's scored

44Publications

1.4kTotal Citations

First publication: 2012First senior author: 2014

Top publicationsby citations

Potential systemic effects of acquired CFTR dysfunction in COPD

Marc Miravitlles, Pablo Altman|Respiratory Medicine|2023

Cited by 11

Indexing the rest of 44 publications…